MaxWell USA, LLC will hold its first annual international symposium on medical and pharmaceutical research and business in the Commonwealth of Independent States (CIS) on 28 May at the Ritz-Carlton Hotel in downtown Washington, DC, USA.
The symposium, entitled “21st century pharmaceutical production and health care research & delivery in the Commonwealth of Independent States,” will consist of a “research track” and a “business track” and includes panel sessions on: Oncology, cardiology and immunology; Perspectives on Ukrainian medicine today; and global sourcing and supply of pharmaceutical equipment and ingredients.
The Honorable Curt Weldon – former Member of Congress – will give the keynote speech.
“Current life expectancy in Ukraine is very low, due to cardiovascular, oncological and autoimmune diseases,” said Dr Kenneth Alibek, founder, president and CEO of MaxWell Biocorporation.
“MaxWell is committed to bringing much-needed drugs and new principles of medical care to help advance the healthcare system of Ukraine as well as other countries of the CIS.”
“This symposium, which will bring Ukrainian and American medical professionals together, is the first step to begin the process of creating a more effective health system in these countries.”
The symposium will be conducted in Ukrainian, Russian and English, with simultaneous translation available. Cost to attend the symposium is US$295 per person.